Catalog
Online
Added:03/14/2025 09:51
Speakers: Craig Chepke, MD, DFAPA; Philip Gehrman, Ph.D., CBSM, FAASM; Anne Marie Morse, DO, FAASM
Learning Objectives:
• Describe the bidirectional relationship of sleep-wake and psychiatric disorders.
• Evaluate the uses and limitations of traditional pharmacotherapies and consider the potential contributions of novel/investigational pharmacotherapies for sleep-wake disorders in psychiatry patients.
• Identify clinical characteristics that raise suspicion for sleep-wake disorders and specific questions to ask to improve their detection and diagnosis in psychiatry patients.
Learning Objectives:
• Describe the bidirectional relationship of sleep-wake and psychiatric disorders.
• Evaluate the uses and limitations of traditional pharmacotherapies and consider the potential contributions of novel/investigational pharmacotherapies for sleep-wake disorders in psychiatry patients.
• Identify clinical characteristics that raise suspicion for sleep-wake disorders and specific questions to ask to improve their detection and diagnosis in psychiatry patients.
Credits awarded per Session. See individual Sessions for further details.
Credits awarded
Type
Name
Sub type
Value
Already successfully completed: re-enrollment available!
Recently Added Items
About this item
Speakers: Craig Chepke, MD, DFAPA; Philip Gehrman, Ph.D., CBSM, FAASM; Anne Marie Morse, DO, FAASM
Learning Objectives:
• Describe the bidirectional relationship of sleep-wake and psychiatric disorders.
• Evaluate the uses and limitations of traditional pharmacotherapies and consider the potential contributions of novel/investigational pharmacotherapies for sleep-wake disorders in psychiatry patients.
• Identify clinical characteristics that raise suspicion for sleep-wake disorders and specific questions to ask to improve their detection and diagnosis in psychiatry patients.
Learning Objectives:
• Describe the bidirectional relationship of sleep-wake and psychiatric disorders.
• Evaluate the uses and limitations of traditional pharmacotherapies and consider the potential contributions of novel/investigational pharmacotherapies for sleep-wake disorders in psychiatry patients.
• Identify clinical characteristics that raise suspicion for sleep-wake disorders and specific questions to ask to improve their detection and diagnosis in psychiatry patients.
Ratings and reviews
Type:
Name:
Sub type:
Value: